4 years of historical data (2021–2024) · Consumer Defensive · Household & Personal Products
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Solesence, Inc. Common Stock trades at 18.3x earnings, 70% below its 5-year average of 61.4x, sitting at the 0th percentile of its historical range. Compared to the Consumer Defensive sector median P/E of 21.6x, the stock trades at a discount of 15%.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $90M | $159M | $30M | $56M | $207M |
| Enterprise Value | $104M | $173M | $49M | $71M | $221M |
| P/E Ratio → | 18.29 | 34.86 | — | — | 88.00 |
| P/S Ratio | 1.72 | 3.03 | 0.80 | 1.49 | 7.02 |
| P/B Ratio | 5.57 | 10.62 | 15.63 | 9.83 | 27.73 |
| P/FCF | — | — | — | — | 463.03 |
| P/OCF | 45.81 | 80.50 | — | — | 89.17 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Solesence, Inc. Common Stock's enterprise value stands at 17.2x EBITDA, 66% below its 5-year average of 50.9x. The Consumer Defensive sector median is 12.3x, placing the stock at a 40% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| EV / Revenue | — | 3.30 | 1.32 | 1.91 | 7.50 |
| EV / EBITDA | 17.19 | 28.47 | — | — | 73.37 |
| EV / EBIT | 20.30 | 33.62 | — | — | 62.96 |
| EV / FCF | — | — | — | — | 494.56 |
Margins and return-on-capital ratios measuring operating efficiency
Solesence, Inc. Common Stock earns an operating margin of 9.8%, above the Consumer Defensive sector average of 1.1%. Operating margins have expanded from -6.1% to 9.8% over the past 3 years, signaling improving operational efficiency. Return on equity of 50.3% is exceptionally high — well above the sector median of 7.8%. ROIC of 15.3% represents solid returns on invested capital versus a sector median of 5.7%.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Gross Margin | 30.9% | 30.9% | 21.0% | 22.4% | 29.5% |
| Operating Margin | 9.8% | 9.8% | -9.5% | -6.1% | 8.7% |
| Net Profit Margin | 8.1% | 8.1% | -11.8% | -7.0% | 7.9% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| ROE | 50.3% | 50.3% | -116.3% | -40.0% | 31.1% |
| ROA | 10.2% | 10.2% | -13.2% | -8.5% | 8.2% |
| ROIC | 15.3% | 15.3% | -12.4% | -7.9% | 8.9% |
| ROCE | 24.7% | 24.7% | -19.2% | -11.1% | 12.2% |
Solvency and debt-coverage ratios — lower is generally safer
Solesence, Inc. Common Stock carries a Debt/EBITDA ratio of 2.5x, which is moderately leveraged (22% below the sector average of 3.2x). Net debt stands at $14M ($15M total debt minus $1M cash). Interest coverage of 7.7x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Debt / Equity | 1.02 | 1.02 | 11.18 | 3.20 | 1.98 |
| Debt / EBITDA | 2.52 | 2.52 | — | — | 4.90 |
| Net Debt / Equity | — | 0.93 | 10.27 | 2.82 | 1.89 |
| Net Debt / EBITDA | 2.29 | 2.29 | — | — | 4.68 |
| Debt / FCF | — | — | — | — | 31.53 |
| Interest Coverage | 7.66 | 7.66 | -4.23 | -5.91 | 2.22 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.14x means Solesence, Inc. Common Stock can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.35x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.20x to 1.14x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Current Ratio | 1.14 | 1.14 | 1.05 | 1.20 | 1.58 |
| Quick Ratio | 0.35 | 0.35 | 0.40 | 0.56 | 0.75 |
| Cash Ratio | 0.05 | 0.05 | 0.11 | 0.16 | 0.09 |
| Asset Turnover | — | 1.05 | 1.13 | 1.11 | 1.04 |
| Inventory Turnover | 1.78 | 1.78 | 2.94 | 3.28 | 3.41 |
| Days Sales Outstanding | — | 33.95 | 33.93 | 46.30 | 48.75 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Solesence, Inc. Common Stock does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 5.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Earnings Yield | 5.5% | 2.9% | — | — | 1.1% |
| FCF Yield | — | — | — | — | 0.2% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $65M | $50M | $49M | $47M |
Compare SLSN with 8 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| SLSNYou | $90M | 18.3 | 17.2 | — | 30.9% | 9.8% | 50.3% | 15.3% | 2.5 |
| CL | $80B | 37.7 | 17.4 | 22.0 | 60.1% | 21.3% | 469.1% | 43.4% | 1.6 |
| EL | $13B | -34.8 | 10.7 | 18.7 | 73.9% | 6.7% | -24.7% | 6.5% | 5.3 |
| ELF | $5B | 47.9 | 26.2 | 44.5 | 71.2% | 12.0% | 16.0% | 13.5% | 1.5 |
| IPAR | $3B | 19.7 | 10.9 | 17.7 | 63.9% | 18.9% | 17.9% | 20.6% | 0.6 |
| COTY | $2B | -5.7 | 9.3 | 7.9 | 64.8% | 4.1% | -9.0% | 2.3% | 6.4 |
| EPC | $1B | 42.9 | 12.8 | 25.7 | 41.6% | 4.3% | 1.6% | 2.6% | 8.3 |
| DSY | $179M | 254.5 | 163.4 | — | 66.9% | -0.4% | 2.4% | -0.1% | 2.6 |
| AXIL | $46M | 68.0 | 32.2 | 30.1 | 71.0% | 4.4% | 9.9% | 17.0% | 0.6 |
| Consumer Defensive Median | — | 21.6 | 12.3 | 16.4 | 40.7% | 1.1% | 7.8% | 5.7% | 3.2 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 4 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how SLSN stacks up against sector leader Colgate-Palmolive Company.
Start ComparisonSolesence, Inc. Common Stock's current P/E ratio is 18.3x. The historical average is 61.4x.
Solesence, Inc. Common Stock's current EV/EBITDA is 17.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 50.9x.
Solesence, Inc. Common Stock's return on equity (ROE) is 50.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -18.7%.
Based on historical data, Solesence, Inc. Common Stock is trading at a P/E of 18.3x. Compare with industry peers and growth rates for a complete picture.
Solesence, Inc. Common Stock has 30.9% gross margin and 9.8% operating margin.
Solesence, Inc. Common Stock's Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.